HHealthcare Read More Meet Ottava, J&J’s surgical robot leading the healthcare giant into a lucrative new marketSeptember 11, 2026 Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…
HHealthcare Read More Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare StocksSeptember 10, 2026 On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli…
HHealthcare Read More Johnson & Johnson Stock Jumps 3% as Healthcare Rotation Lifts SharesAugust 19, 2026 This article first appeared on GuruFocus. Johnson & Johnson (NYSE:JNJ), the healthcare heavyweight behind blockbuster medicines and medical…
AArtificial intelligence Read More Inflation moderated as Intel and Nvidia fueled the AI trade in last week’s marketAugust 15, 2026 No surprises on inflation and new financing developments in the artificial intelligence trade drove the record-breaking action on…
HHealthcare Read More Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?August 11, 2026 Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo…
HHealthcare Read More Johnson & Johnson (JNJ) Could Be 10% Overvalued Following Leadership ChangeAugust 6, 2026 Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
PPersonal finance Read More How a 44-Year-Old Could Build a $9,000 Monthly Paycheck by 60 Without Maxing a 401(k)July 29, 2026 Quick Read Generating $108,000 annually from dividends requires roughly $2.7M at a 4% yield, $1.8M at 6%, or…
PPersonal finance Read More Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a PaycheckJuly 28, 2026 Quick Read Realty Income (O) yields 5.11% with 670 consecutive monthly dividends, while Verizon (VZ) anchors the group…
HHealthcare Read More Johnson & Johnson (JNJ) Raised Its Outlook. Is It the Better Healthcare Stock to Own After Earnings?July 28, 2026 Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7%…
HHeadlines Read More Johnson & Johnson offers $5.5bn to settle lawsuits, as it rejects claims talc products caused cancerJuly 28, 2026 US PHARMACEUTICAL GIANT Johnson & Johnson has offered $5.5 billion (€4.83 billion) to settle tens of thousands of…
HHealthcare Read More J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.July 24, 2026 Intuitive Surgical Inc location sign-by Sundry Photography via iStock Intuitive Surgical (ISRG) shares closed lower on July 22…
HHealthcare Read More J&J enters US robotic surgery market after device gets marketing authorizationJuly 24, 2026 By Puyaan Singh July 22 (Reuters) – Johnson & Johnson said on Wednesday the U.S. Food and Drug…